| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.091 | 0.09 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.076 | 0.1 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.081 | 0.1 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.081 | 0.2 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.061 | 0.3 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.051 | 0.3 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.047 | 0.4 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.039 | 0.5 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.041 | 0.5 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.026 | 0.6 |